Recent Antiphospholipid Syndrome News:
- https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1639277/xml
- Want signs of bipartisanship? In the House, look to women. – South Carolina Daily Gazette
- Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis – MDPI
- Strubenvale mother tells about miscarriage, high-risk pregnancy and NICU journey
- Planning critical to avoid ‘catastrophic’ accidental pregnancies, abortion in rheumatology
- Bipartisan resolution aims to protect Black mothers through expanded prenatal screening
- Pitfalls in Coagulation Testing: A Pediatric Case of Lupus Anticoagulant …
- Lupus, lupus nephritis may be part of ‘overlapping spectrum’ – Healio
- GLP-1s cost effective for weight loss in knee osteoarthritis – Healio
- Roivant and Pfizer-backed Priovant post late-stage trial win for dermatomyositis therapy
- DWTS: Carrie Ann Inaba to Miss Season 34 Premiere. Will She be Replaced? – Mjsbigblog
- Want signs of bipartisanship? In the House, look to women. – Michigan Advance
- High Thromboembolic Events in New-Onset SLE With APS – Medscape
- Anxiety, bipolar disorder risks nearly twice as high in patients with autoimmune disease
- Refractory Digital Ulcers in Systemic Sclerosis Sine Scleroderma Associated With …
- Refractory Digital Ulcers in Systemic Sclerosis Sine Scleroderma Associated With …
- Global Catastrophic Antiphospholipid Syndrome Market Size, – openPR.com
- Key proteins in rare autoimmune disease identified – Medical Xpress
- VolitionRX stock rating reiterated at Buy by H.C. Wainwright – Investing.com
- Congress Introduces New Legislation to Reform Protecting Access to Medicare Act | 360Dx
- Johns Hopkins Researchers Develop RNA-Based Prostate Cancer Panel, Plan for Spinout Company
- VolitionRx shares rise 4.08% premarket after signing a licensing deal with Werfen for APS …
- Study shows healthy newborns at risk for RSV – YouTube
- H. Res. 685 (IH) – Expressing support for testing for antiphospholipid syndrome (APS) as a …
- Unraveling the Mysteries of APS Vasculopathy – BIOENGINEER.ORG
- North Central Florida congresswoman Kat Cammack supports bill to expand prenatal screenings
- Bipartisan Lawmakers work to expand prenatal screening – Spectrum News
- Press Release: Cammack and Kamlager-Dove Introduce Bipartisan Resolution to Expand …
- VolitionRx and Werfen Collaborate on Antiphospholipid Syndrome Diagnosis – AInvest
- VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome
- Chart-topping singer lends star power to life-or-death pregnancy battle | Daily Mail Online
- Volition Signs APS Research And Licensing Agreement With Werfen – RTTNews
- Volition, Werfen Sign Licensing, Commercialization Deal for Antiphospholipid Syndrome Test
- VedaBio Licenses Mammoth Biosciences Diagnostic CRISPR Technology – 360Dx
- Bruker Raises $690M in Public Offering of Mandatory Convertible Preferred Stock
- VolitionRx signs licensing deal with Werfen for blood clot test – StreetInsider
- Unravelling the Role of TET2 in Venous Thromboembolism: Insights into Mechanisms and …
- Multiple Dural Venous Sinus Thromboses in a Young Female Presenting With Refractory Headaches
- VolitionRx shares rise 3.93% intraday after signing a licensing deal with Werfen for APS diagnostics.
- Volition Signs First Human Out-Licensing Deal for Nu.Q NETs Test with Werfen’s … – AInvest
- VolitionRx (NYSE American: VNRX) Signs Deal with Worldwide Leader in Specialized Diagnostics
- VolitionRx (VNRX) Enters Agreement with Werfen for APS Research – GuruFocus
- Volition signs research license agreement with Werfen for APS testing – Investing.com
- VolitionRx signs first human out licensing deal for APS – TipRanks.com
- Volition Signs First Human Out Licensing Deal – Yahoo Finance
- Cammack, Kamlager-Dove, and Christina Perri launch bipartisan effort to expand prenatal …
- Severe Pediatric Arterial Thrombosis in Antiphospholipid Syndrome and Systemic Lupus …
- Relapsing Chronic Immune Thrombocytopenia and Thrombosis: A Case Report | Cureus
- DWP confirms full list of 178 medical conditions that qualify for up to £749 – Wales Online
- First Year Is Worst for Clotting Events in Lupus Patients – MedPage Today
Antiphospholipid Syndrome News:
- Nine research updates in thrombosis treatment, surveillance and risk prediction.
-
Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.
-
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.
-
Heart attack: New finding may change the face of treatment
-
Hughes syndrome (antiphospholipid syndrome) and the nervous system.
-
When autoimmune diseases exert neuro-ophthalmic effects
-
Catastrophic antiphospholipid syndrome: The current management approach.
- 2016 review on catastrophic antiphospholipid syndrome.
-
Pregnancy and APS: Results Look Encouraging
-
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
-
Anticoagulating patients with high-risk acquired thrombophilias.
-
Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE
-
Catastrophic antiphospholipid syndrome: The current management approach.
- Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome. case report
- C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
- Myasthenia gravis is sometimes found in conjunction with antiphospholipid syndrome with: A case report
- Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
- Good news for prospective mothers with antiphospholipid syndrome? – Journal of Postgraduate Medicine
- New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases
- Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist
- Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review